Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
about
Small airway inflammation in asthmaMonitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion modelUse of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmaticsIs Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?The effects of inhaled corticosteroids on growth in children.Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment optionsUse of a novel one-nostril mask-spacer device to evaluate airway hyperresponsiveness (AHR) in horses after chronic administration of albuterolRisk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Value of inhaled corticosteroid therapy in long-term asthma management.Safety of inhaled corticosteroids in children.The role of platelets in the pathophysiology of asthma.Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsRisk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma.Comparative effectiveness of inhaled corticosteroids for paediatric asthma: protocol for a systematic review and Bayesian network meta-analysis.Advances in the management of pediatric asthma: a review of recent FDA drug approvals and label updates.Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.Comparison of inhaled corticosteroids: an update.Leukotriene modifiers in the treatment of asthma in children.Inhalation therapy in asthmatic and not asthmatic children.Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.Role of leukotriene receptor antagonists in the management of pediatric asthma: an update.Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma.Efficacy and safety of two dry-powder inhalers for the administration of mometasone furoate in asthma patients.Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids.Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.Inhaled hydrofluoalkane-beclomethasone dipropionate in bronchopulmonary dysplasia. A double-blind, randomized, controlled pilot study.Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives
P2860
Q24798859-455B6032-F5CC-4F0D-BD8B-151834021580Q24805892-1FEB416B-3E67-466A-8B82-950EDC9268E3Q28066822-898131D8-6379-4612-A270-EDA77406D337Q28550366-DA1EAB71-801D-4212-8E68-CD6D80218AB2Q30419000-162470BB-5B64-49FF-A6C0-DF0C0E88AF15Q33644839-B27172EE-DA7B-4FDD-A122-5E2F7D9B4451Q33797784-63C8F265-F8B4-4F57-89E1-11FF5EF2D776Q33803143-D70CDF3E-8B82-4E2F-9C25-85BD14A824B6Q34027961-68967F60-ADB2-4B6A-90FF-69A9C0243A57Q34523194-26FB7095-078D-406D-A9F5-A043EE1E7A50Q34656136-49C9D13B-2A3D-42AE-B766-DE98CB2DE89FQ35583186-9532C2A9-7E90-4EA3-819B-295F4C9EF176Q35610011-12A7CCB8-AAA2-43DA-BCFA-0A72A17E2B56Q35855205-13BD2275-97F3-4C4F-AA16-5809DF943515Q36205132-7CF73B9B-A50C-44A2-8F75-07421AE1B317Q36305143-E9D99B9B-0E9E-42C4-BC9B-1437717189B7Q36782563-F7D11658-A717-4370-8969-FD3CB7BA22F7Q37390386-7FD0EEEE-04AB-4C7B-9282-537778ADDACCQ37406595-6A46A04C-315C-4F26-97CE-D0188ACB14FAQ37613312-416799B8-B4F7-4B86-BACB-4C86832936D6Q37950135-3D2CF0C3-07CE-43B8-89FE-19CF0C3BF897Q37979251-CB7C17E5-1F56-4C99-B0FE-395019161434Q38034994-B4EEBEFD-4D30-4985-9DFC-2DCAE6D49CF0Q38759118-DAADB9D7-B506-44AF-A1A7-D97FC1528E90Q40109458-9F8E20E4-B047-44CF-9D51-CD03C699725EQ42909622-90617121-B4FF-4348-B290-B8B7241DF7DCQ48006092-0A87BB4A-3503-4036-BD8B-73BA28FFA771Q50915470-BABFFB9D-803C-4BA2-98A5-BDDF2681FB66Q50969851-8392F72A-CCB0-4186-B9C9-2D7192CBEC53Q51442641-29ADA7A0-DC64-45CE-AD37-AA00F094242CQ55007666-CF2DBC52-E5D3-46FB-8592-687C80696B21Q58877120-660203EF-D860-4991-ACB8-B3D4818491AE
P2860
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@ast
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@en
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@nl
type
label
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@ast
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@en
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@nl
prefLabel
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@ast
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@en
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@nl
P2093
P356
P1476
Efficacy and safety overview o ...... nhalation aerosol), in asthma.
@en
P2093
J A Vanden Burgt
R J Martin
S J Szefler
P304
P356
10.1067/MAI.2000.111582
P407
P577
2000-12-01T00:00:00Z